Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Neurosci ; 24(4): 489-503, 2021 04.
Article in English | MEDLINE | ID: mdl-33603230

ABSTRACT

Neurodegeneration occurring in multiple sclerosis (MS) contributes to the progression of disability. It is therefore important to identify and neutralize the mechanisms that promote neurodegeneration in MS. Here, we report that oxidized phosphatidylcholines (OxPCs) found in MS lesions, previously identified as end-product markers of oxidative stress, are potent drivers of neurodegeneration. Cultured neurons and oligodendrocytes were killed by OxPCs, and this was ameliorated by microglia. After OxPC injection, mouse spinal cords developed focal demyelinating lesions with prominent axonal loss. The depletion of microglia that accumulated in OxPC lesions exacerbated neurodegeneration. Single-cell RNA sequencing of lesioned spinal cords identified unique subsets of TREM2high mouse microglia responding to OxPC deposition. TREM2 was detected in human MS lesions, and TREM2-/- mice exhibited worsened OxPC lesions. These results identify OxPCs as potent neurotoxins and suggest that enhancing microglia-mediated OxPC clearance via TREM2 could help prevent neurodegeneration in MS.


Subject(s)
Membrane Glycoproteins/metabolism , Microglia , Multiple Sclerosis , Nerve Degeneration , Phosphatidylcholines/toxicity , Receptors, Immunologic/metabolism , Animals , Humans , Mice , Multiple Sclerosis/metabolism , Multiple Sclerosis/pathology , Nerve Degeneration/metabolism , Nerve Degeneration/pathology , Neurons/drug effects , Oligodendroglia/drug effects , Oxidation-Reduction , Phosphatidylcholines/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...